Thin melanomas and regression, thick melanomas and older men: Prognostic implications and perspectives on secondary prevention

Archives of Dermatology

Volumn 138, Issue 5, 2002, Pages 678-682

  Demierre, Marie France ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; CANCER REGRESSION; CLINICAL FEATURE; CORRELATION ANALYSIS; EDITORIAL; ELDERLY CARE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SKIN CANCER;

HUMANS; MELANOMA; NEOPLASM METASTASIS; PROGNOSIS; REMISSION, SPONTANEOUS; SKIN NEOPLASMS;

EID: 0036578659     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (63)

1. Histological characteristics of metastasizing thin melanomas: A case-control study of 43 cases
2. The regressing thin malignant melanoma
3. A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods
4. Prognostic significance of the histological features of malignant melanoma
5. Prognosis in patients with thin malignant melanoma: Influence of regression
6. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness: An appraisal of 'thin' level IV lesions
7. Regression in thin malignant melanoma: Microscopic diagnosis and prognostic importance
8. Spontaneous regression of melanoma
9. Common and uncommon melanocytic nevi and borderline melanomas
10. Regression in malignant melanoma: A histologic feature without prognostic significance
11. Regression and other factors of prognostic interest in malignant melanoma
12. Thin malignant melanomas with regression and metastases
13. Histologic regression in malignant melanoma: An interobserver concordance study
14. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma
15. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
16. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
17. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
18. Review and current perspectives of cutaneous malignant melanoma
19. Partial regression in thin primary cutaneous malignant melanomas clinical stage I: A study of 486 cases
20. Histologic features of tumors, and the female superiority in survival from malignant melanoma
21. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology: CRC Melanoma Pathology Panel
22. Recent incidence trends imply a non-metastasizing form of invasive melanoma
23. Thin malignant melanomas (less than 1.5 mm) with metastasis: A histological study and survival analysis
24. Patients presenting with thin melanomas (less than 0.76 mm thick) who subsequently have a poor prognosis by development of metastases
25. The metastasizing thin cutaneous melanoma: Case report
26. Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases
27. Lethal "thin" malignant melanoma
28. Metastasis and death in patients with thin melanomas (less than 0.76 mm)
29. Biologic behavior ofthin malignant melanomas with regressive changes
30. Regression in malignant melanoma
31. Thin melanomas with unusual aggressive behavior: A report of nine cases
32. Recurrence potential of thin primary melanomas
33. Prognostic factors in thin cutaneous malignant melanoma
34. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma
35. Cutaneous melanomas exhibiting unusual biologic behavior
36. Gender and cutaneous melanoma
37. A prognostic model for predicting 10-year survival in patients with primary melanoma
38. Prognostic clinical and pathologic features
39. Guidelines of care for primary cutaneous melanoma
40. Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma
41. Vascular involvement in the prognosis of primary cutaneous melanoma
42. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia
43. Factors involved in presentation of older people with melanoma
44. Factors related to the presentation of patients with primary melanomas
45. Nodular histogenetic type-the most significant factor for thick melanoma: Implications for prevention
46. Increasing incidence of cutaneous melanoma in Queensland, Australia
47. Update on the incidence and mortality from melanoma in the United States
48. Analysis of the melanoma epidemic, both apparent and real
49. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
50. Recent trends in cutaneous melanoma incidence among whites in the United States
51. Melanoma screening and education
52. Audit of primary and secondary melanoma prevention
53. Malignant melanoma in the elderly
54. Cutaneous melanoma in association with other skin cancers
55. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi
56. The relation of basal-cell carcinomas and squamous cell carcinomas to solar keratoses
57. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma
58. Sun exposure and the risk of melanoma
59. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits
60. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals
61. The pathogenesis of melanoma induced by ultraviolet radiation
62. Should mass screening for skin cancer be targeted to middle-aged and older men? findings from the United States